220 related articles for article (PubMed ID: 15639679)
1. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients.
Vanhorebeek I; De Vos R; Mesotten D; Wouters PJ; De Wolf-Peeters C; Van den Berghe G
Lancet; 2005 Jan 1-7; 365(9453):53-9. PubMed ID: 15639679
[TBL] [Abstract][Full Text] [Related]
2. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy.
Mesotten D; Swinnen JV; Vanderhoydonc F; Wouters PJ; Van den Berghe G
J Clin Endocrinol Metab; 2004 Jan; 89(1):219-26. PubMed ID: 14715853
[TBL] [Abstract][Full Text] [Related]
3. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
[TBL] [Abstract][Full Text] [Related]
4. Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure.
Fredriksson K; Hammarqvist F; Strigård K; Hultenby K; Ljungqvist O; Wernerman J; Rooyackers O
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1044-50. PubMed ID: 16803854
[TBL] [Abstract][Full Text] [Related]
5. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol.
Shulman R; Finney SJ; O'Sullivan C; Glynne PA; Greene R
Crit Care; 2007; 11(4):R75. PubMed ID: 17623086
[TBL] [Abstract][Full Text] [Related]
6. Modulating the endocrine response in sepsis: insulin and blood glucose control.
Vanhorebeek I; Langouche L; Van den Berghe G
Novartis Found Symp; 2007; 280():204-15; discussion 215-22. PubMed ID: 17380796
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness.
Vanhorebeek I; Ellger B; De Vos R; Boussemaere M; Debaveye Y; Perre SV; Rabbani N; Thornalley PJ; Van den Berghe G
Crit Care Med; 2009 Apr; 37(4):1355-64. PubMed ID: 19242345
[TBL] [Abstract][Full Text] [Related]
8. Intensive insulin therapy in the medical ICU.
Van den Berghe G; Wilmer A; Hermans G; Meersseman W; Wouters PJ; Milants I; Van Wijngaerden E; Bobbaers H; Bouillon R
N Engl J Med; 2006 Feb; 354(5):449-61. PubMed ID: 16452557
[TBL] [Abstract][Full Text] [Related]
9. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.
Meyfroidt G; Keenan DM; Wang X; Wouters PJ; Veldhuis JD; Van den Berghe G
Crit Care Med; 2010 Apr; 38(4):1021-9. PubMed ID: 20124887
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol improves insulin resistance of catch-up growth by increasing mitochondrial complexes and antioxidant function in skeletal muscle.
Zheng J; Chen LL; Zhang HH; Hu X; Kong W; Hu D
Metabolism; 2012 Jul; 61(7):954-65. PubMed ID: 22209670
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance.
Larsen S; Stride N; Hey-Mogensen M; Hansen CN; Bang LE; Bundgaard H; Nielsen LB; Helge JW; Dela F
J Am Coll Cardiol; 2013 Jan; 61(1):44-53. PubMed ID: 23287371
[TBL] [Abstract][Full Text] [Related]
12. Indication and practical use of intensive insulin therapy in the critically ill.
Mebis L; Gunst J; Langouche L; Vanhorebeek I; Van den Berghe G
Curr Opin Crit Care; 2007 Aug; 13(4):392-8. PubMed ID: 17599008
[TBL] [Abstract][Full Text] [Related]
13. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.
Krinsley JS
Mayo Clin Proc; 2004 Aug; 79(8):992-1000. PubMed ID: 15301325
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial fusion, fission, and biogenesis in prolonged critically ill patients.
Vanhorebeek I; Gunst J; Derde S; Derese I; Boussemaere M; D'Hoore A; Wouters PJ; Van den Berghe G
J Clin Endocrinol Metab; 2012 Jan; 97(1):E59-64. PubMed ID: 22013100
[TBL] [Abstract][Full Text] [Related]
15. FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival.
Thiessen SE; Vanhorebeek I; Derese I; Gunst J; Van den Berghe G
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1319-27. PubMed ID: 26274346
[TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness.
Mesotten D; Delhanty PJ; Vanderhoydonc F; Hardman KV; Weekers F; Baxter RC; Van Den Berghe G
J Clin Endocrinol Metab; 2002 Dec; 87(12):5516-23. PubMed ID: 12466347
[TBL] [Abstract][Full Text] [Related]
17. Lowering of glucose in critical care: a randomized pilot trial.
McMullin J; Brozek J; McDonald E; Clarke F; Jaeschke R; Heels-Ansdell D; Leppert R; Foss A; Cook D
J Crit Care; 2007 Jun; 22(2):112-8; discussion 118-9. PubMed ID: 17548021
[TBL] [Abstract][Full Text] [Related]
18. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit.
Hermans G; Wilmer A; Meersseman W; Milants I; Wouters PJ; Bobbaers H; Bruyninckx F; Van den Berghe G
Am J Respir Crit Care Med; 2007 Mar; 175(5):480-9. PubMed ID: 17138955
[TBL] [Abstract][Full Text] [Related]
19. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients.
Derde S; Hermans G; Derese I; Güiza F; Hedström Y; Wouters PJ; Bruyninckx F; D'Hoore A; Larsson L; Van den Berghe G; Vanhorebeek I
Crit Care Med; 2012 Jan; 40(1):79-89. PubMed ID: 21926599
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial protein synthesis is increased in oxidative skeletal muscles of rats with cardiac cachexia.
Thibault R; Chanséaume S; Azarnoush K; Guillet C; Giraudet C; Patrac V; Lusson JR; Cano N; Boirie Y; Walrand S
Nutr Res; 2014 Mar; 34(3):250-7. PubMed ID: 24655492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
